Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Lispro PK/PD in Lipohypertrophic vs Normal Tissue
NCT02221323Phase 2Completed
- Sponsor
- Profil
- Start
- Sep 2014
- Primary completion
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of insulin lispro in type 1 diabetes mellitus (T1D) (2 arms), sponsored by Profil. Primary endpoints: Area Under the Curve for Insulin (0-4h) and Area Under the Curve for Glucose Infusion Rate (0-4h). Started Sep 2014; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02221323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02221323.